But institutional investors RARELY TOUCH even 1 share of a pinky stock... For two of them to be buying this early says a lot about how they view of the potential here.
Its sooo damn good, its worth the risk to be the early bird.
Current position size is not the important thing at this point. It's that they have a position at all that speaks volumes...again, rare that institutions would even touch a pink stock.
AMFE Institutional Ownership Portfolio Breakdown
Assets Under Management (AUM) Oxbow Advisors: $1.483 Billion Summit Global Investments: $720 Million Combined Total AUM: $2.203B
Managed Securities (As of Q1 2018) Oxbow Advisors: $490.5M Summit Global Investments: $628.5M Combined Managed Securities: $1.119B
We've got two whales kicking the AMFE tires. Wonder if they would consider a larger investment as the Snakes U.S.A. rollout gets underway? Would they be impressed with more acquisitions in the distribution and publishing areas? Snakes global expansion? What about Gro3 in Canada, California, Colombia?
If these two both decided to increase their AMFE position to only a half of 1% of their portfolio, which would be nowhere near their largest holdings, it would be worth $5.6M.
At an average share price of .20, that money would buy up 28 million shares. A drop in the bucket for them. And this is only two of the whales that we know of that are sniffing around Amfil.